Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Heart Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's6 (66.67)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alloatti, G; Hirsch, E; Lembo, G; Montrucchio, G1
Sawaragi, I; Takashima, M; Yasuda, K1
Chello, M; Mastroroberto, P; Perticone, F1
Feuerstein, G; Leor, J; Rabinovici, R; Vonhof, S; Winkler, JD1
Quinn, JV; Slotman, GJ1
Goldfarb, R1
Beatch, GN; Pugsley, MK; Salari, H; Walker, MJ1
Lefer, AM1
Alberton, M; Camussi, G; Coda, R; Macchiorlatti, E; Mariano, F; Montrucchio, G; Mularoni, E; Roffinello, C; Tetta, C1

Reviews

4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Diseases

ArticleYear
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.
    Biochemical Society transactions, 2004, Volume: 32, Issue:Pt 2

    Topics: Animals; Cardiovascular System; Class Ib Phosphatidylinositol 3-Kinase; Cyclic AMP; Disease Models, Animal; Heart Diseases; Humans; Isoenzymes; Mice; Mice, Transgenic; Myocardial Ischemia; Nitric Oxide; Phenotype; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Receptors, G-Protein-Coupled; Signal Transduction

2004
Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.
    Journal of lipid mediators and cell signalling, 1997, Volume: 15, Issue:3

    Topics: Animals; Cells, Cultured; Coronary Vessels; Heart; Heart Diseases; Heart Transplantation; Humans; Molecular Structure; Myocardial Contraction; Myocardial Ischemia; Myocardium; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled

1997
Investigations into the polydeterminant nature of sepsis.
    Critical care medicine, 1999, Volume: 27, Issue:11

    Topics: Animals; Arachidonic Acid; Eicosanoids; Heart Diseases; Humans; Hypertension, Pulmonary; Platelet Activating Factor; Shock, Septic; Tumor Necrosis Factor-alpha

1999
Platelet activating factor (PAF) and its role in cardiac injury.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: Animals; Coronary Disease; Heart; Heart Diseases; Platelet Activating Factor

1989

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Diseases

ArticleYear
Influence of a cigarette smoke extract on the hormonal regulation of platelet-activating factor acetylhydrolase in rats.
    Biology of reproduction, 1995, Volume: 53, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aging; Animals; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Heart Diseases; Intestines; Lung; Medroxyprogesterone; Myocardium; Nicotiana; Phospholipases A; Plants, Toxic; Platelet Activating Factor; Rats; Rats, Wistar; Smoke; Thrombosis

1995
Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis.
    Scandinavian journal of thoracic and cardiovascular surgery, 1996, Volume: 30, Issue:2

    Topics: Atrial Function; Blood Pressure; Case-Control Studies; Echocardiography, Doppler, Color; Embolism; Fibrin Fibrinogen Degradation Products; Heart Diseases; Heart Failure; Heart Valve Prosthesis; Hemostasis; Humans; Ischemic Attack, Transient; Linear Models; Middle Aged; Mitral Valve; Platelet Activating Factor; Pulmonary Artery; Stroke Volume; Systole; Thrombosis; Ventricular Function, Left; Ventricular Pressure; von Willebrand Factor

1996
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Critical care medicine, 1999, Volume: 27, Issue:11

    Topics: Aeromonas hydrophila; Animals; Arachidonic Acid; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Eicosanoids; Female; Gram-Negative Bacterial Infections; Heart Diseases; Hemodynamics; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Masoprocol; Oxazoles; Oxygen; Oxygen Consumption; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Swine; Thromboxane A2; Triazoles; Tumor Necrosis Factor-alpha

1999
The effects of platelet activating factor on isolated rat hearts.
    Proceedings of the Western Pharmacology Society, 1990, Volume: 33

    Topics: Animals; Blood Pressure; Coronary Circulation; Heart; Heart Diseases; In Vitro Techniques; Male; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains

1990
The role of platelet-activating factor in experimental immune complex pathology.
    International journal of tissue reactions, 1985, Volume: 7, Issue:5

    Topics: Animals; Antigen-Antibody Complex; Blood Vessels; Capillary Permeability; Chemical and Drug Induced Liver Injury; Complement C3; Female; Heart Diseases; Immune Complex Diseases; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Platelet Activating Factor; Rabbits

1985